Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share (BGMS)

Q: What does CUSIP 23254L876 represent in this 13F holders report?

CUSIP 23254L876 is the security identifier for BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share in Q2 2025?

1 institutional investor reported BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 23254L876

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 5,519,894
Total 13F shares: 75
Share change: +75
Total reported value: $25
Price per share: $0.33
Number of holders: 1
Value change: +$25
Number of buys: 1

Quarterly Holders Quick Answers

What is CUSIP 23254L876?
CUSIP 23254L876 identifies BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025

Recent filing periods for CUSIP 23254L876:

Q1 2026 Q4 2025 Q3 2025 Q2 2025

Top shareholders of BGMS - Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Datuk Dr. Doris Wong Sing Ee	13D/G	Doris Wong Sing Ee	70%	194,628,820	$58,388,646	$0	26 Feb 2025	13D/G
ARMISTICE CAPITAL, LLC	13F	Company	80%	1,269,485	$354,440	—	31 Mar 2025	13F
David Natan	3/4/5	Director	— mixed-class rows	800,000 mixed-class rows	$331,500	—	26 Feb 2025	3/4/5
Spiro George Rombotis	3/4/5	President and CEO, Director	— mixed-class rows	184,728 mixed-class rows	$227,601	—	21 Dec 2023	3/4/5
Kenneth M. Ferguson	3/4/5	Director	— mixed-class rows	87,390 mixed-class rows	$149,016	—	30 Jun 2023	3/4/5
Karin L. Walker	3/4/5	Director	— mixed-class rows	83,040 mixed-class rows	$134,596	—	30 Jun 2023	3/4/5
Sam L. Barker	3/4/5	Director	— mixed-class rows	82,853 mixed-class rows	$133,976	—	30 Jun 2023	3/4/5
Christopher S. Henney	3/4/5	Director	— mixed-class rows	81,853 mixed-class rows	$130,661	—	30 Jun 2023	3/4/5
Robert J. Spiegel	3/4/5	Director	— mixed-class rows	81,853 mixed-class rows	$130,661	—	30 Jun 2023	3/4/5
Paul McBarron	3/4/5	E. VP, Fin, CFO, COO and Secretary, Director	— mixed-class rows	105,464 mixed-class rows	$110,648	—	21 Dec 2023	3/4/5
CITADEL ADVISORS LLC	13F	Company	— mixed-class rows	64,092 mixed-class rows	$73,160	—	31 Mar 2025	13F
Lloyd Sems	3/4/5	Director	— mixed-class rows	49,841 mixed-class rows	$60,320	—	14 Jun 2022	3/4/5
Brian Schwartz	3/4/5	Interim Chief Medical Officer, Director	— mixed-class rows	27,705 mixed-class rows	$50,405	—	29 Jan 2024	3/4/5
UBS Group AG	13F	Company	— mixed-class rows	67,627 mixed-class rows	$42,536	—	31 Mar 2025	13F
Shay Capital LLC	13F	Company	7%	110,919	$30,969	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	3.9%	62,467	$17,440	—	31 Mar 2025	13F
VSM Wealth Advisory, LLC	13F	Company	— class O/S missing	2,777	$12,995	—	31 Mar 2025	13F
Gregory T. Hradsky	3/4/5	Director	— mixed-class rows	7,122 mixed-class rows	$7,870	—	15 Jun 2021	3/4/5
TWO SIGMA SECURITIES, LLC	13F	Company	1%	16,218	$4,528	—	31 Mar 2025	13F
Point72 Asset Management, L.P.	13F	Company	0.97%	15,333	$4,281	—	31 Mar 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.96%	15,286	$4,268	—	31 Mar 2025	13F
XTX Topco Ltd	13F	Company	0.9%	14,285	$3,988	—	31 Mar 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.39%	6,255	$1,746	—	31 Mar 2025	13F
Sound Income Strategies, LLC	13F	Company	— class O/S missing	94	$440	—	31 Mar 2025	13F
SBI Securities Co., Ltd.	13F	Company	0.08%	1,202	$336	—	31 Mar 2025	13F
Archer Investment Corp	13F	Company	0.01%	200	$56	—	31 Mar 2025	13F
Financial Gravity Asset Management, Inc.	13F	Company	0.01%	200	$56	—	31 Mar 2025	13F
Activest Wealth Management	13F	Company	0.01%	133	$37	—	31 Mar 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	0.01%	126	$34	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.01%	80	$22	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	54	$15	—	31 Mar 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	33	$9	—	31 Mar 2025	13F
SIGNATUREFD, LLC	13F	Company	0%	20	$6	—	31 Mar 2025	13F
HARBOUR INVESTMENTS, INC.	13F	Company	0%	13	$4	—	31 Mar 2025	13F
DANSKE BANK A/S	13F	Company	0%	2	$1	—	31 Mar 2025	13F
Avraham Ben-Tzvi	3/4/5	Director	— class O/S missing	700,000	—	—	26 Feb 2025	3/4/5
Ho Jien Shiung	3/4/5	Shareholder	— class O/S missing	250,000	—	—	29 Apr 2025	3/4/5
Ho Kee Wee	3/4/5	Shareholder	— class O/S missing	250,000	—	—	29 Apr 2025	3/4/5
Sukses Engineering Sdn Bhd Suria	3/4/5	Shareholder	— class O/S missing	250,000	—	—	29 Apr 2025	3/4/5
Tan Kok Hui	3/4/5	Shareholder	— class O/S missing	250,000	—	—	29 Apr 2025	3/4/5
Mark Kirschbaum	3/4/5	Chief Medical Officer	— class O/S missing	70,200	—	—	30 Jun 2023	3/4/5

Institutional Holders of Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share (BGMS) as of Q2 2025

As of 30 Jun 2025, Bio Green Med Solution, Inc. - Common Stock, par value $0.001 per share (BGMS) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 75 shares. The largest 1 holders included SBI Securities Co., Ltd.. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q4 2025 Across Filers

Q4 2025 holders

Q2 2025 holders

Holder diff

-8

Investor	Q4 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.